Pharmaceuticals

Delhi HC allows Biocon, Mylan to sell generic drug for three types of cancers

04 Mar 2017

NPPA to meet stent manufacturers as hospitals continue to flout order

03 Mar 2017

India beware: WHO publishes list of drug-resistant bugs

02 Mar 2017

Bayer to fund $66-bn Monsabto deal from Covestro-stake sale

02 Mar 2017

Perrigo to sell royalties of multiple sclerosis drug Tysabri to Royalty Pharma for up to $2.85 bn

01 Mar 2017

WHO publishes first list of drug-resistant killer bugs

28 Feb 2017

The list was drawn up to guide and promote research and development of new antibiotics, as part of WHO’s efforts to address growing resistance among bacteria to medicines currently in use

Lupin gets US FDA nod for marketing generic Percocet tablets

28 Feb 2017

Advent International outbids Cinven, Bain with €3.6-bn offer for Stada Arzneimittel

24 Feb 2017

Govt invokes special powers to ensure steady supply of coronary stents

22 Feb 2017

Manufacturers have been ordered to submit a weekly report on coronary stents produced and distributed besides a weekly production plan to the drug pricing authority

AstraZeneca licenses cancer drug Zoladex to TerSera Therapeutics

21 Feb 2017

Price cap: latest stents disappear from hospitals, stockists

17 Feb 2017

Authorities crack down on stent ‘hoarders’ after price caps

17 Feb 2017

The government will use various provisions of the Essential Commodities Act to penalise those found illegally and unethically profiteering or hoarding stents

Statin side effects are strongest predictor of failure to meet cholesterol targets

15 Feb 2017

Merck calls off late-stage trial of Alzheimer’s drug verubecestat

15 Feb 2017

India slashes stent prices by up to 85%; cap at Rs30,000

14 Feb 2017

In a major relief for heart patients, the National Pharmaceutical Pricing Authority has fixed the ceiling price of drug eluting stents (DES) and bioresorbable stents at Rs30,000 and of bare metal stents at Rs7,500

Allergan to buy body-contouring product maker Zeltiq Aesthetics for $2.48 bn

14 Feb 2017

Apax Partners in talks to buy Israeli aesthetic device company Syneron Medical

13 Feb 2017

German generic drugmaker Stada receives $3.83-bn takeover bid from Cinven Partners

13 Feb 2017

Sanofi nears deal to sell some OTC products to Ipsen SA

13 Feb 2017

Reckitt Benckiser to acquire Mead Johnson for $16.6 bn in cash

10 Feb 2017

The deal will help Reckitt Benckiser boost its consumer-health business and push deeper into emerging markets with Mead Johnson's portfolio

Regeneron and Sanofi need not pull Praluent off market

09 Feb 2017

LabCorp in talks to buy Pharmaceutical Product Development for more than $8 bn

06 Feb 2017

Spread of drug-resistant malaria bug should worry India: expert

04 Feb 2017

Detection of malaria parasites resistant to the frontline artemisinin (ART) combination therapy in some south Asian countries should worry India, Govindarajan Padmanabhan, a top biochemist and malaria researcher at the Indian Institute of Science in Bengaluru, has warned

Pfizer explores sale of some treatment drugs worth over $2 bn

03 Feb 2017

As a part of its plan to raise cash and streamline its portfolio, Pfizer will sell its cardiology, urology and primary care treatment drugs

Trump tells drug makers to get prices down

01 Feb 2017